Lydia Visser
7PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 10, 2025
Programmed cell death-1 inhibition activates CD4 T cells in a novel in vitro model of Hodgkin lymphoma.Rodrigo Martinez Alcala, Yajie Lei, Lydia Visser
|Oct 25, 2024
Enhancing the Cytotoxicity and Apoptotic Efficacy of Parasporin-2-Derived Variants (Mpp46Aa1) on Cancer Cell Lines.Juan S Alarcón-Aldana, Lydia Visser, Nohora J Rueda-Forero
|Apr 11, 2024
Small-Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells.Chao Wang, Bidong Zhang, Yingying Cong
|May 27, 2023
Toxic Determination of Cry11 Mutated Proteins Obtained Using Rational Design and Its Computational Analysis.Miguel O Suárez-Barrera, Diego F Herrera-Pineda, Paola Rondón-Villarreal
|Nov 26, 2022
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma.Myra Langendonk, Nienke A M Smit, Wouter Plattel
|Nov 11, 2022
Site-Directed Mutants of Parasporin PS2Aa1 with Enhanced Cytotoxic Activity in Colorectal Cancer Cell Lines.Miguel O Suárez-Barrera, Lydia Visser, Efraín H Pinzón-Reyes
Pageof 2
Frequent Collaborators
3 joint publications
Nohora Juliana Rueda-Forero
3 joint publications
Paola Rondón-Villarreal
2 joint publications
Arjan Diepstra
2 joint publications
Miguel O Suárez-Barrera
1 joint publications
Bidong Zhang
1 joint publications
Siyao Chen
1 joint publications
Johanna Veldman
1 joint publications
Lili Zhang
1 joint publications
Fulvio Reggiori
1 joint publications
Matthew R Groves
